相关实验视频

Updated: May 5, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

使用5%的乳糖绝缘剂来预防脑神经损伤:一个案例报告

Mehmet Özgeyik¹, Ramazan Anıl Eşki², Özge Turgay Yıldırım¹

¹Ministry of Health Eskisehir City Hospital, Eskişehir, Turkey.

Pacing and clinical electrophysiology : PACE

|February 18, 2026

概括

一种新的技术,使用5%的水中的牛精糖 (D5W) 作为心表绝缘介质,成功地保护了神经在节修改不适当的鼻高心率 (IST) 期间. 这种方法使得无线电频率的安全传输成为可能,降低了神经受伤的风险.

科学领域:

电力生理学电力生理学
心血管医学心血管医学
最少侵入性手术的方法

背景情况:

药物耐药性不适合性鼻高心率 (IST) 的治疗受限于鼻节修改期间的神经损伤风险,特别是在右上心房和上静脉附近.
在表心除过程中有效地隔离神经仍然是一个重大挑战.

研究的目的:

描述一种新的技术,用于用于药物耐药性IST中的鼻节修饰,采用皮肤上心膜方法.
评估使用水中5%的乳糖 (D5W) 作为绝缘介质在上心除过程中保护神经的疗效和安全性.

主要方法:

一名患有症状性,抗药性IST的患者在失败的内心脏切除后通过皮肤上皮心脏方法进行了鼻节修饰.
5%的水中的乳糖 (D5W) 被注射到心周空间中,以隔离和保护神经在射频传递过程中.

主要成果:

急性手术取得了成功,鼻率显著降低,症状改善.
在心上表膜射频消去过程中没有发生神经损伤.

结论:

使用D5W作为心表绝缘介质,可用于神经附近的鼻结修饰.
发生了心周并发症,包括输出和粘附,需要仔细选择患者和评估手术技术.

更多相关视频

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Published on: February 10, 2023

相关概念视频

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...